-transparent.png){kind=logo}
A Bayesian drug dosing program was prospectively evaluated in 16 hospitalized patients with obstructive respiratory disease treated with a novel sustained-release preparation Euphylong. Theophylline was given as a single evening dose. By means of the Bayesian method, the early morning peak was predicted from a steady-state theophylline serum level determined at 8:00 a.m. The prediction errors were in all cases within a clinically acceptable range (mean prediction error +/- standard deviation: -0.2 +/- 1.3 mg/L). The results were compared with predictions based on steady state theophylline serum levels at 8:00 p.m. The prediction errors observed were on average greater than the prediction errors based on the serum levels at 8:00 a.m. (-0.6 +/- 2.5 mg/L). These findings suggest that the Bayesian method is useful for dosage predictions in patients treated once a day with Euphylong.
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
January 1987,
Respiration; international review of thoracic diseases,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
January 1981,
Acta medica Scandinavica,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
September 1987,
British journal of clinical pharmacology,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
February 2004,
Journal of clinical pharmacy and therapeutics,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
October 1986,
Chest,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
January 1996,
Pharmacotherapy,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
January 1985,
Pharmacotherapy,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
September 1986,
Drug intelligence & clinical pharmacy,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
December 1985,
The American journal of medicine,
W Martz, and
M Oellerich, and
D Schnabel, and
G W Sybrecht
January 1988,
European journal of drug metabolism and pharmacokinetics,
